RxSight cut to hold at Stifel on competition concerns

by
Contributor since / Followers

19 hours ago

RxSight (NASDAQ:RXST), a maker of light-adjustable intraocular lenses, traded lower on Friday after Stifel downgraded the company to Hold from Buy, citing concerns over its market competition.
Citing a survey of LAL-trained surgeons, analyst Thomas Stephan pointed to a worse-than-feared competition

Tags: JNJ